 | | | | The U.S. health regulator has determined that the current authorized dose of GlaxoSmithKline Plc and Vir Biotechnology's antibody-based COVID-19 treatment is unlikely to be effective against the Omicron BA.2 variant, the companies said on Friday. | | | | | | Italy reported 75,616 COVID-19 related cases on Friday, against 81,811 the day before, the health ministry said, while the number of deaths fell to 146 from 182. | | | | | | French health authorities said the number of patients hospitalised for COVID-19 were down by 38 over 24 hours, at 20,616, but on a week-on-week basis, that figure was up for the second day running, after declining by that measure since early February. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | The estimated range of England's COVID-19 reproduction "R" number is between 1.1 and 1.4, the UK Health Security Agency said on Friday. | | | | | | Here's what you need to know about the coronavirus pandemic right now: | | | | | | Hong Kong will gradually resume public services from April 1, the government said on Friday, with the global financial hub posting its lowest number of daily infections in about a month. | | | | | | Japan's Shionogi & Co has signed a basic agreement with the government to supply an oral COVID-19 treatment it is now developing, the firm said on Friday. | | | | | | The European Medicines Agency on Friday recommended the use of Johnson & Johnson and its partner Legend Biotech Corp's CAR-T therapy to treat multiple myeloma, nearly a month after the treatment was cleared in the United States. | | | | | | Germany's health minister on Friday urged people over age 60 with risk factors such as high blood pressure or a weak heart to get a second booster shot against COVID-19 to reduce their risk of getting seriously ill. | | | | | |
